Action of selected serotonin antagonists on hyperthermia evoked by intracerebrally injected beta-endorphin.
Methergoline, an antagonist of cerebral serotonin receptors, has been shown to significantly reduce the rise in rectal temperature (Tre) produced by the intracerebral microinjection of beta-endorphin. In this study the role of serotonin in the increase in Tre elicited by beta-endorphin was further examined using three additional serotonin antagonists. beta-Endorphin was administered twice to rats using a crossover design in which half of the animals were first pretreated with the vehicle solution and half with the antagonist. Serotonin antagonists used were: methergoline, methysergide, cinanserin and cyproheptadine. Although methergoline did cause a marked reduction in the beta-endorphin-induced rise in Tre, neither methysergide, nor cinanserin, nor cyproheptadine produced a marked reduction in the hyperthermia. Since methergoline also interacts with the dopamine receptor, the effect of a dopamine antagonist, haloperidol, on the endorphin-evoked response was also examined. Haloperidol failed to attenuate the rise in Tre. The reason for the apparent discrepancy in the action of these serotonin antagonists is unclear. Further research may reveal distinct subpopulations of serotonin receptors at which these antagonists exert differential effects.
D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001833:Body Temperature Regulation / Q000187:drug effects*; D002928:Cinanserin / Q000494:pharmacology; D004723:Endorphins / Q000494:pharmacology*; D005334:Fever; D006220:Haloperidol / Q000494:pharmacology; D008711:Metergoline / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D051381:Rats; D012702:Serotonin Antagonists / Q000494:pharmacology*; D001615:beta-Endorphin
D004723:Endorphins; D012702:Serotonin Antagonists; D008711:Metergoline; D001615:beta-Endorphin; D006220:Haloperidol; D002928:Cinanserin; D008784:Methysergide